cell-therapy

Documents about cell-therapy

• JMJD3 and UTX as key targets for gene-modified mesenchymal stem cell therapy in cartilage tissue engineering#364094HAL (France)
• GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC#366579ClinicalTrials.gov
• T cell immunity predicts clinical outcomes on stopping antiretroviral treatment after HIV-specific broadly neutralising antibody therapy#387697Europe PMC
• Protocol for mitochondria lipid encapsulation using a dual-tube system for mitochondria transfer therapy#408877IRIS
• KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer#411388ClinicalTrials.gov
• Study to Evaluate the Safety and Efficacy of ESC-derived Dopamine Progenitor Cell Therapy in PD Patients#424239ClinicalTrials.gov
• Feasibility and Implementation of a Group Therapy Program for Adults Living With Chronic Pain and Sickle Cell Disease.#452730NCBI PubMed Central
• Camrelizumab as a Maintenance Therapy After Chemoradiation in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma#474783ClinicalTrials.gov
• Mesenchymal Stem Cell Therapy of Dry Eye Disease in Patients With Sjögren's Syndrome#802429ClinicalTrials.gov
• Efficacy Assessment of the Cell Therapy Medicine NC1 in Patients With Post-traumatic Syringomyelia#805628ClinicalTrials.gov
• Cognitive Behavioral Therapy and Real-time Self-management Intervention for SCD Via Mobile Applications#847852ClinicalTrials.gov
• Autologous Stem Cells in Osteoarthritis#855984ClinicalTrials.gov
• Donepezil and Vitamin E to Prevent Side Effects Caused By Radiation Therapy to the Head in Patients Receiving Treatment for Small Cell Lung Cancer#813364ClinicalTrials.gov
• High-Dose 3-Dimensional Conformal Radiation Therapy in Treating Patients With Inoperable Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer#852217ClinicalTrials.gov
• A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First- Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU)#860117ClinicalTrials.gov
• Aggressive Natural Killer Cell Leukemia: A Rare and Rapidly Progressive Hematologic Malignancy—Case Report and Literature Review#211595ODU Digital Commons
• Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian Cancer#356532ClinicalTrials.gov
• Spatially fractionated x-rays integrated with live-cell microscopy to study early responses to minibeam radiation therapy#445584HAL (France)
• Tislelizumab Combined With Chemotherapy for Different Cycles of Neoadjuvant Therapy for Locally Advanced Resectable Squamous Cell Carcinoma of the Head and Neck (NeoTempo)#807182ClinicalTrials.gov
• Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma#827585ClinicalTrials.gov
• Metronomic Oral Vinorelbine in Patients With Metastatic Tumors#829949ClinicalTrials.gov
• A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants With Relapsed or Refractory Multiple Myeloma#830756ClinicalTrials.gov
• A Study of CNCT19 Treatment in Children and Adolescent r/r ALL Patients(Pediatric)#833406ClinicalTrials.gov
• Study Investigating NTLA-5001 in Subjects With Acute Myeloid Leukemia#837371ClinicalTrials.gov
• Cultural Tailoring and Pilot Testing of an Inpatient Yoga Therapy Program for Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation in India, Tanzania, and the United States#838072ClinicalTrials.gov
• A Study of BL-B01D1 in Combination With Osimertinib as Perioperative Therapy in Patients With EGFR-mutated Resectable Non-small Cell Lung Cancer(PANKU-Lung09)#845606ClinicalTrials.gov
• A Study of TQB2450 Injection Combined With Stereotactic Body Radiation Therapy (SBRT) in Subjects With Advanced Oligometastatic Non-Small Cell Lung Cancer#852100ClinicalTrials.gov
• Expanded Access Program With Nivolumab Therapy for Treatment of Advanced/Metastatic SqNSCLC or Non-SqNSCLC After One Prior Systemic Regimen#863354ClinicalTrials.gov
• Monoclonal Antibody Therapy in Relapsed Non-Hodgkin's After Chemotherapy and Autologous Stem Cell Transplantation#845893ClinicalTrials.gov
• Consolidation Sintilimab After Concurrent Chemoradiation in Patients With Unresectable Stage III NSCLC#806483ClinicalTrials.gov
• Human and Insect Cell-Produced Recombinant Adeno-Associated Viruses Show Differences in Genome Heterogeneity#176852HAL (France)
• Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy#303573ClinicalTrials.gov
• Fludeoxyglucose F-18-PET in Planning Lung Cancer Radiation Therapy#852328ClinicalTrials.gov
• Generation of Pure Highly Functional Human Anti-Tumor Specific Cytotoxic T Lymphocytes With Stem Cell-Like Memory Features for Melanoma Immunotherapy#126895HAL (France)
• Table 1_Immunomodulatory effects of HUC-MSCs therapy: enhancing adaptive and innate immune responses in aging frailty.xlsx#361734Figshare
• Deciphering the Renal tumOr microenvironment to PersonaLize immunE-targeted Treatment (DROPLET): transcriptomic profiling of primary and secondary lesions identified a potential crosstalk between MARCO+ macrophages and deregulated cancer-cell proliferation in mediating progression and therapy response of advanced renal cell carcinoта.#823162IRIS
• Allo-HSCT Vs. Auto-HSCT for PTCL Patients With PR After First-line Systemic Therapy : A Prospective, Multicenter, Cohort Study-(T-START-PR)#830256ClinicalTrials.gov
• Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery#847548ClinicalTrials.gov
• An Optimized Conversion of Spermatogonial Stem Cells Into Spinal Cord Neurons Enhances Functional Recovery in Rats After Spinal Cord Injury#120121Europe PMC
• INVESTIGATING THE POTENTIAL OF UMBILICAL CORD BLOOD-DERIVED GAMMA DELTA T CELLS AS A THERAPEUTIC APPROACH IN HEAD AND NECK SQUAMOUS CELL CANCER#247204ScholarBank@NUS
• A novel approach to systemic delivery of therapies in muscular dystrophies through engineering of hematopoietic stem cells#330012HAL (France)
• AML96 - Risk-Adapted and Randomized Postremission-Therapy for Adult Acute Myeloid Leukemia Patients#826959ClinicalTrials.gov
• Expanded Use of G-CSF Mobilized Donor CD34+ Selected Cells for Allogeneic Transplantation#829470ClinicalTrials.gov
• A Study on the Correlation Between Tarceva (Erlotinib) - Induced Rash and Efficacy in EGFR Mutated Participants With Advanced Non-Small Cell Lung Cancer Receiving First-Line Therapy#856002ClinicalTrials.gov
• Study Evaluating the Efficacy and Safety With CAR-T for Relapsed or Refractory Neuroblastoma in Children#125819ClinicalTrials.gov
• NK Cell Therapy for Malignant Solid Brain Tumors#140984ClinicalTrials.gov
• Anti-CLL1 CAR T-cell Therapy in CLL1 Positive Relapsed/Refractory Acute Myeloid Leukemia (AML)#141008ClinicalTrials.gov
• The inhibitory effect of hepatic cancer energy metabolism on immune checkpoint therapy: perspectives from single-cell multi-omics analysis.#143246NCBI PubMed Central
• Cyclophosphamide, TAPA-Pulsed Dendritic Cell Therapy and Imiquimod in Progressive and/or Refractory Solid Malignancies#195327ClinicalTrials.gov
• Zn(ii)-based metal-organic frameworks with tailored architectures: optimizing fluorescence performance for cell imaging and cancer therapy.#199140NCBI PubMed Central